Emerging and Chinese pharmas playing greater role in oncology drug development (NYSE:MRK)
Luis Alvarez While many of the top-selling cancer therapeutics are sold by some of the largest pharmaceutical companies, an increasing ...
Luis Alvarez While many of the top-selling cancer therapeutics are sold by some of the largest pharmaceutical companies, an increasing ...
© Reuters. Thursday - Elevation Oncology (NASDAQ:ELEV) has received a new Market Outperform rating from JMP Securities, accompanied by an ...
© Reuters. On Wednesday, H.C. Wainwright initiated coverage on CG Oncology (NASDAQ:CGON), issuing a Buy rating and setting a price ...
Oncology company NovoCure (Nasdaq: NVCR), which has developed a novel therapy for solid tumors using electric fields, has announced ...
© Reuters. Pharmaceutical giant Bristol-Myers Squibb (NYSE:) is set to acquire cancer drug manufacturer Mirati Therapeutics (NASDAQ: NASDAQ:) in a ...
Elevation Oncology (ELEV) Climbs 57% (Updated - May 26, 2023 10:50 AM EDT) Elevation Oncology (ELEV) Climbs 57%Hedge fund Point72 ...
Precision oncology biomarkers are essential tools for tailoring cancer treatment to individual patients, as they provide insights into tumor biology ...
The field of oncology has witnessed substantial changes with various emerging technologies and an increasing focus on precision medicine for ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.